Office therapeutic drug monitoring.
Considerations necessary for appropriate therapeutic drug monitoring in the office practice setting have been presented. Practical issues focusing on clinical pharmacokinetics as well as serum drug concentration evaluation methods and techniques have been reviewed, with emphasis on orally administered medications.
D004077:Digoxin / Q000627:therapeutic use; D004358:Drug Therapy; D005260:Female; D006268:Health Facilities; D006801:Humans; D007700:Kinetics; D007753:Laboratories; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D004364:Pharmaceutical Preparations / Q000097:blood / Q000378:metabolism*; D010824:Physicians' Offices; D013048:Specimen Handling; D013806:Theophylline / Q000627:therapeutic use
D004364:Pharmaceutical Preparations; D004077:Digoxin; D013806:Theophylline